Cargando…

MOC31PE immunotoxin – targeting peritoneal metastasis from epithelial ovarian cancer

Peritoneal metastasis (PM) is an important feature of epithelial ovarian cancer (EOC) and is a frequent site of drug resistant disease recurrence, identifying PM-EOC an important clinical challenge. The MOC31PE immunotoxin targets and kills tumor cells expressing the epithelial cell adhesion molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Yvonne, Haavardtun, Synne Ihler, Davidson, Ben, Dørum, Anne, Fleten, Karianne G., Fodstad, Øystein, Flatmark, Kjersti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617465/ https://www.ncbi.nlm.nih.gov/pubmed/28977905 http://dx.doi.org/10.18632/oncotarget.18694

Ejemplares similares

The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells
por: Wiiger, Merete Thune, et al.
Publicado: (2014)

Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2021)

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
por: Andersson, Y, et al.
Publicado: (2015)

Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
por: Risberg, Karianne, et al.
Publicado: (2011)

Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
por: Andersson, Yvonne, et al.
Publicado: (2021)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
por: Fleten, Karianne Giller, et al.
Publicado: (2020)

Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
por: Andersson, Y, et al.
Publicado: (2009)

Ep-CAM (MOC-31) expression in tooth germ and ameloblastoma
por: Derderian, Nathalie, et al.
Publicado: (2022)

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
por: Flatmark, Kjersti, et al.
Publicado: (2021)

Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
por: Fleten, Karianne Giller, et al.
Publicado: (2021)

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
por: Borowiec, Marta, et al.
Publicado: (2016)

Metastatic Seminoma with Positive Staining of Cytokeratin and MOC31: A Diagnostic Pitfall
por: Fan, Jiaming, et al.
Publicado: (2021)

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
por: Saelen, Marie Grøn, et al.
Publicado: (2012)

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
por: Ingebrigtsen, Vibeke A, et al.
Publicado: (2014)

Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery
por: Fleten, Karianne Giller, et al.
Publicado: (2022)

moc-6/MOCS2A is necessary for molybdenum cofactor synthesis in C. elegans
por: Snoozy, Jennifer, et al.
Publicado: (2022)

Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium
por: Lim, Daejin, et al.
Publicado: (2017)

Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
por: Saelen, Marie Grøn, et al.
Publicado: (2011)

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers
por: Falahatgar, Dianoush, et al.
Publicado: (2018)

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
por: Wang, Chunguang, et al.
Publicado: (2016)

MOC Reports issued in 1958 and 1959
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1960)

Diagnostic Utility of Caveolin-1 and MOC-31 in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
por: Lee, Hyoun Wook, et al.
Publicado: (2011)

Pseudomyxoma peritonei – two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
por: Flatmark, Kjersti, et al.
Publicado: (2007)

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
por: Flatmark, Kjersti, et al.
Publicado: (2006)

Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
por: Wei, Xu, et al.
Publicado: (2011)

Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors
por: Sokolova, E. A., et al.
Publicado: (2015)

Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity
por: Jun, Sei-Yong, et al.
Publicado: (2022)

Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems
por: Krebs, Simon K., et al.
Publicado: (2022)

Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25
por: Peng, Yanjie, et al.
Publicado: (2023)

Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
por: Schee, Kristina, et al.
Publicado: (2013)

Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion
por: Park, Sangsu, et al.
Publicado: (2021)

MOC-Diatomite Composites Filled with Multi-Walled Carbon Nanotubes
por: Pavlíková, Milena, et al.
Publicado: (2021)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

EpCAM (MOC-31) – immunohistochemical expression in papillary thyroid carcinoma and non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
por: Ben Rejeb, Sarra, et al.
Publicado: (2021)

Beyond Moco Biosynthesis―Moonlighting Roles of MoaE and MOCS2
por: Suganuma, Tamaki
Publicado: (2022)

MOC Composites for Construction: Improvement in Water Resistance by Addition of Nanodopants and Polyphenol
por: Lauermannová, Anna-Marie, et al.
Publicado: (2023)

A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a6qk3mrgfgfnnnms9tgfbgfimt